STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1335 by analyst upside · 2026-06-27
RZLT
Rezolute, Inc.
Healthcare · Market Cap $485M · P/E 0x
ANALYST PRICE TARGET
+52.1%
implied upside to consensus target
Current Price $5.04
Consensus Target $7.67
Bull Target $14.0
Bear Target $4.0
Analysts Covering 9
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
5
Hold
3
Sell
0
52-Week Low $1.07
52-Week High $11.46
YTD Return +132.8%
FUNDAMENTALS
Market Cap $485M
P/E Ratio (TTM) N/A
Forward P/E -8.0x
EPS (TTM) $-0.81
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $1.07
52-Week High $11.46
Current Price $5.04
Bear Target $4.0
Bull Target $14.0
● Now $5.04 ● Target $7.67
TRADING DATA
Avg Volume 1.7M
YTD Return +132.8%
Analyst Count 9
Consensus Buy
Upside to Target +52.1%
Last Updated 2026-06-27

ANALYST SUMMARY

Rezolute, Inc. (RZLT) is currently trading at $5.04 with a Wall Street consensus price target of $7.67, implying potential upside of 52.1% over the next 12 months. 9 analysts currently cover RZLT, with a consensus rating of Buy - 67% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $14.0, while the most cautious has a target of $4.0.

RZLT operates in the Healthcare sector with a market capitalisation of $485M. The stock is up 132.8% year-to-date and is currently trading near the lower end of its 52-week range of $1.07 – $11.46.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for RZLT, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Guggenheim — Reiterated
Buy → Buy 2026-06-15 62% win rate (8 calls)
Maxim Group — Reiterated
Buy → Buy 2026-06-03 28% win rate (40 calls)
Citizens ↑ Upgrade
Market Perform → Market Outperform 2026-06-03 Building track record
Wedbush — Reiterated
Outperform → Outperform 2026-06-03 Building track record
HC Wainwright & Co. reit
Buy → Buy 2026-06-02 31% win rate (48 calls)
BTIG — Reiterated
Buy → Buy 2026-06-02 38% win rate (8 calls)
Maxim Group — Reiterated
Buy → Buy 2026-05-14 28% win rate (40 calls)
Wedbush ↑ Upgrade
Neutral → Outperform 2026-03-25 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
32
out of 100
Coverage depth
18/30
Consensus clarity
0/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →